Product information and disease description
Place of product in therapy
35 evidence topics · 30 sources
Lonvoguran ziclumeran (lonvo-z)
Hereditary angioedema
- Manufacturer
- Intellia Therapeutics
- Regulatory submission
- Rolling BLA initiated April 2026 and accepted September 2026
- Last updated